Improvement of leucocyte functions in ovariectomised aged rats after treatment with growth hormone, melatonin, oestrogens or phyto-oestrogens.
Ageing is accompanied by an impairment of the physiological activity of the nervous, endocrine and immune system, as well as in neuroendocrine-immune communication. However, age-related changes in this communication axis have been scarcely studied. In mammals, the process of ageing is associated with an important decline in the secretion of several hormones, such as growth hormone (GH), melatonin (MEL) and oestrogens (Os). Ovariectomy, a model of menopause in rats, has been found to lead to premature immunosenescence. In the present study, the effect of ovariectomy and the role of replacement therapies with GH, MEL, O and natural phyto-oestrogens (POs) have been assessed on several functions in leucocytes from the spleen and the axillary nodes of intact and ovariectomised rats. Chemotaxis, lymphoproliferative response to the mitogen concanavalin A (Con A), the release of interleukin-2 (IL-2) and the natural killer (NK) cell activity have been investigated. Age-controlled rats were used to compare immune functions in hormone treated aged rats with those in younger untreated animals. In all experimental groups, the immune impairment caused by ageing and ovariectomy was partially or completely reversed by hormone treatments. Since the immune system is a marker of health and a predictor of longevity, the results suggest that treatment with hormones could slow down the effects of the ageing process.
Baeza
I
I
Department of Physiology, Faculty of Biological Sciences, Complutense University of Madrid, 28040 Madrid, Spain.
Alvarado
C
C
Alvarez
P
P
Salazar
V
V
Castillo
C
C
Ariznavarreta
C
C
Fdez-Tresguerres
J A
JA
De la Fuente
M
M
D000367:Age Factors; D000375:Aging; D000818:Animals; D049109:Cell Proliferation; D002633:Chemotaxis / Q000187:drug effects / Q000276:immunology; D003208:Concanavalin A / Q000276:immunology / Q000378:metabolism; D003602:Cytotoxicity, Immunologic; D005260:Female; D013006:Growth Hormone / Q000008:administration & dosage*; D006801:Humans; D007376:Interleukin-2 / Q000378:metabolism; D007694:Killer Cells, Natural / Q000276:immunology / Q000378:metabolism; D008550:Melatonin / Q000008:administration & dosage*; D008593:Menopause / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D010052:Ovariectomy; D048789:Phytoestrogens / Q000008:administration & dosage*; D051381:Rats; D017208:Rats, Wistar; D011994:Recombinant Proteins / Q000008:administration & dosage*
D007376:Interleukin-2; D048789:Phytoestrogens; D011994:Recombinant Proteins; D003208:Concanavalin A; D013006:Growth Hormone; D008550:Melatonin